Lymph Node Carcinoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Sources

Aliases & Classifications for Lymph Node Carcinoma

MalaCards integrated aliases for Lymph Node Carcinoma:

Name: Lymph Node Carcinoma ¹¹ ¹⁴

Lymph Node Cancer ¹¹ ¹⁴ ⁷¹

Lymph Node Neoplasm ¹¹ ¹⁹

Neoplasm of Lymph Node ⁷¹

Classifications:

MalaCards categories:
Global: Rare diseases Cancer diseases
Anatomical: Immune diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹¹ DOID:0080618 DOID:10619

NCIt ⁴⁹ C35497

SNOMED-CT ⁶⁸ 127232002

UMLS ⁷¹ C0596869 C0948627

Sources

Summaries for Lymph Node Carcinoma

Disease Ontology ¹¹ Lymph node carcinoma: A lymph node cancer that has material basis in abnormally proliferating cells derives from epithelial cells.

Lymph node cancer: A lymphatic system cancer that is located in the lymph node.

MalaCards based summary: Lymph Node Carcinoma, also known as lymph node cancer, is related to lymph node adenoid cystic carcinoma and lymphoma, hodgkin, classic. An important gene associated with Lymph Node Carcinoma is H2AC18 (H2A Clustered Histone 18), and among its related pathways/superpathways is TRP channels. The drugs Nivolumab and Ipilimumab have been mentioned in the context of this disorder. Affiliated tissues include lymph node, prostate and breast.

Sources

Related Diseases for Lymph Node Carcinoma

Diseases related to Lymph Node Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 54)

#	Related Disease	Score	Top Affiliating Genes
1	lymph node adenoid cystic carcinoma	11.2
2	lymphoma, hodgkin, classic	11.2
3	prostate adenoid cystic carcinoma	10.3	KLK3 AR
4	prostate leiomyoma	10.2	KLK3 AR
5	prostate calculus	10.2	KLK3 AR
6	mediastinal cancer	10.2
7	nodular prostate	10.2	KLK3 FOLH1
8	lymphocele	10.2	KLK3 FOLH1
9	prostatic acinar adenocarcinoma	10.2	KLK3 FOLH1 AR
10	prostate small cell carcinoma	10.2	KLK3 FOLH1 AR
11	prostatic hyperplasia, benign	10.2	KLK3 FOLH1 AR
12	prostate neuroendocrine neoplasm	10.2	KLK3 FOLH1 AR
13	castration-resistant prostate carcinoma	10.2	KLK3 FOLH1 AR
14	prostatic hypertrophy	10.2	KLK3 FOLH1 AR
15	primary cutaneous amyloidosis	10.2	KLK3 FOLH1 AR
16	male reproductive organ benign neoplasm	10.1	KLK3 AR
17	testicular disease	10.1	KLK3 H2AC18 AR
18	sexual health disorder	10.1	H2AC18 AR
19	urethral stricture	10.1	KLK3 FOLH1
20	suppression of tumorigenicity 12	10.1	KLK3 H2AC18 FOLH1 AR
21	prostatic adenoma	10.0	KLK3 AR
22	male reproductive organ cancer	10.0	KLK3 H2AC18 FOLH1 AR
23	familial episodic pain syndrome	10.0	TRPM8 TRPM4
24	prostate disease	10.0	KLK3 H2AC18 FOLH1 AR
25	male reproductive system disease	10.0	KLK3 H2AC18 FOLH1 AR
26	telogen effluvium	10.0	OR2AT4 AR
27	aplastic anemia	10.0
28	histiocytic sarcoma	10.0
29	pancytopenia	10.0
30	fibrosarcoma of bone	10.0
31	histiocytosis	10.0
32	splenomegaly	10.0
33	lymphoma, mucosa-associated lymphoid type	9.9
34	lung cancer susceptibility 3	9.9
35	large cell neuroendocrine carcinoma	9.9
36	head and neck cancer	9.9
37	neuroendocrine carcinoma	9.9
38	endodermal sinus tumor	9.9
39	rectal benign neoplasm	9.9
40	rectum cancer	9.9
41	adenocarcinoma	9.9
42	papillary adenocarcinoma	9.9
43	tubular adenocarcinoma	9.9
44	colorectal cancer	9.9
45	factor vii deficiency	9.9
46	small cell carcinoma	9.9
47	colonic benign neoplasm	9.9
48	larynx cancer	9.9
49	laryngeal benign neoplasm	9.9
50	lung benign neoplasm	9.9

Graphical network of the top 20 diseases related to Lymph Node Carcinoma:

Sources

Symptoms & Phenotypes for Lymph Node Carcinoma

Sources

Drugs & Therapeutics for Lymph Node Carcinoma

Drugs for Lymph Node Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)

#

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Nivolumab

Approved

Phase 2

946414-94-4

2

Ipilimumab

Approved

Phase 2

477202-00-9

3

Immunoglobulins

Phase 2

4

Immune Checkpoint Inhibitors

Phase 2

5

Antibodies

Phase 2

6

Antineoplastic Agents, Immunological

Phase 2

7

Pancrelipase

Approved, Investigational

53608-75-6

8519

8

Pancreatin

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Neoadjuvant Phase II Study of TLR9 Agonist CMP-001 in Combination With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease	Active, not recruiting	NCT03618641	Phase 2	CMP-001
2	A Randomised Controlled Trial Comparing PICO™ Single Use Negative Pressure Wound Therapy System (Smith & Nephew Healthcare Limited, UK) to Conventional Wound Care Following Inguinal Lymphadenectomy for Metastatic Cutaneous Malignancy	Unknown status	NCT02408835
3	Videoscopic Ilioinguinal Lymphadenectomy for Groin Lymph Node Metastases From Melanoma	Completed	NCT02508909
4	Real-time Semi-quantification of Endoscopic Ultrasound Elastography and Contrast-enhancement Using Strain Histograms (SH) and Contrast-enhancement (CE) for the Differentiation of Focal Pancreatic Masses and the Assessment of Lymph Node Involvement	Completed	NCT02459041
5	Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer in Bogota Colombia.	Completed	NCT02156414
6	Tissue Characterisation Using Ultrasound Based Strain Imaging(Elastography)Examining Lesions in the Gastrointestinal Wall, Adjacent Lymph Nodes and Pancreatic Lesions	Completed	NCT01360411
7	Survey of Extremity and Trunk Sarcoma Surgeons Regarding Surgical Management of Lymph Node Basins	Recruiting	NCT04553744
8	Axillary Reverse Mapping (ARM): Validation of Surgical Tecnique in Breast Cancer Surgery	Recruiting	NCT05040685
9	Feasibility Study of High Dose Stereotactic Body Radiation Therapy (SBRT) for Lymph Nodal Lesions in Oligometastatic Patients for Genito-urinary, Gastro-intestinal and Gynaecological Cancer	Active, not recruiting	NCT02570399
10	Quantitative Analysis of 18F-FAPI Dynamic PET/CT for Accurate Differential Diagnosis of Metastatic Lymph Nodes of Esophageal Squamous Cell Carcinoma	Not yet recruiting	NCT05287880

Search NIH Clinical Center for Lymph Node Carcinoma

Sources

Genetic Tests for Lymph Node Carcinoma

Sources

Anatomical Context for Lymph Node Carcinoma

Organs/tissues related to Lymph Node Carcinoma:

FMA: Lymph Node

MalaCards : Lymph Node, Prostate, Breast, Cervix, Testis, Lung, Cortex

Sources

Publications for Lymph Node Carcinoma

Articles related to Lymph Node Carcinoma:

(show top 50) (show all 141)

#	Title	Authors	PMID	Year
1	A novel biorecognition receptor Citropin-A modified impedimetric biosensor for detection of LNCaP prostate cancer cells. ⁶²	Fedaci C...Akcay Y	35688260	2022
2	Connarus semidecandrus Jack Exerts Anti-Alopecia Effects by Targeting 5α-Reductase Activity and an Intrinsic Apoptotic Pathway. ⁶²	Jang WY...Cho JY	35807332	2022
3	Axillary lymph-node metastases as the primary presentation of high-grade serous ovarian carcinoma: A case report. ⁶²	Mirzaei M...Fazilat-Panah D	35441016	2022
4	Prostate-specific membrane antigen (PSMA) targeted singlet oxygen delivery via endoperoxide tethered ligands. ⁶²	Wang L...Akkaya EU	35029263	2022
5	Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617. ⁶²	Dos Santos JC...Mier W	36017165	2022
6	Inflammation induced by lipopolysaccharide advanced androgen receptor expression and epithelial-mesenchymal transition progress in prostatitis and prostate cancer. ⁶²	Wang GC...Peng B	34984192	2021
7	A case of early gastric cancer with a single giant lymph node metastasis. ⁶²	Yoshikawa M...Kito K	34792649	2021
8	Preserving the posterior cortex of the sternum during resection of a superficial anterior chest wall sarcoma. ⁶²	Sakamoto A...Matsuda S	34729167	2021
9	Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. ⁶²	Mirabelli C...Sexton JZ	34413211	2021
10	Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis. ⁶²	Ye B...Qiao Y	34294701	2021
11	Standardization of the [68Ga]Ga-PSMA-11 Radiolabeling Protocol in an Automatic Synthesis Module: Assessments for PET Imaging of Prostate Cancer. ⁶²	Fuscaldi LL...de Barboza MF	33918987	2021
12	Val16A SOD2 Polymorphism Promotes Epithelial-Mesenchymal Transition Antagonized by Muscadine Grape Skin Extract in Prostate Cancer Cells. ⁶²	Sweeney JD...Odero-Marah V	33535682	2021
13	Comprehensive analysis of metastatic gastric cancer tumour cells using single-cell RNA-seq. ⁶²	Wang B...Zhan X	33441952	2021
14	Ectopically expressed olfactory receptors OR51E1 and OR51E2 suppress proliferation and promote cell death in a prostate cancer cell line. ⁶²	Pronin A...Slepak V	33640452	2021
15	The Effect of Arbutin on The Expression of Tumor Suppressor P53, BAX/BCL-2 Ratio and Oxidative Stress Induced by Tert-Butyl Hydroperoxide in Fibroblast and LNcap Cell Lines. ⁶²	Ebadollahi SH...Aghajanpour-Mir M	32347047	2021
16	Epigallocatechin-3-gallate Enhances the Efficacy of MicroRNA-34a Mimic and MicroRNA-93 Inhibitor Co-transfection in Prostate Cancer Cell Line. ⁶²	Mokhtari H...Mahrooz A	33463130	2020
17	Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression. ⁶²	Fan YC...Tsai YC	33322099	2020
18	Androgen Deprivation Induces Transcriptional Reprogramming in Prostate Cancer Cells to Develop Stem Cell-Like Characteristics. ⁶²	Verma S...Gupta S	33339129	2020
19	CD147 promotes epithelial-mesenchymal transition of prostate cancer cells via the Wnt/β-catenin pathway. ⁶²	Fang F...Wang L	32855684	2020
20	Analysis of novel enzalutamide-resistant cells: upregulation of testis-specific Y-encoded protein gene promotes the expression of androgen receptor splicing variant 7. ⁶²	Seki M...Minamiguchi K	35117234	2020
21	Magnetic resonance imaging and photothermal conversion properties of Gd-C nanocomposites for interstitial lymphography. ⁶²	Yao Y...Zhu H	31099983	2020
22	Preliminary in Vitro Studies on Corynebacterium urealyticum Pathogenetic Mechanisms, a Possible Candidate for Chronic Idiopathic Prostatitis? ⁶²	Nicolosi D...Di Marco R	32218312	2020
23	Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes. ⁶²	Carlos Dos Santos J...Mier W	31541034	2020
24	A spatial neighborhood methodology for computing and analyzing lymph node carcinoma similarity in precision medicine. ⁶²	Luciani T...Marai GE	34417010	2020
25	miR-100-5p Downregulates mTOR to Suppress the Proliferation, Migration, and Invasion of Prostate Cancer Cells. ⁶²	Ye Y...Wang JJ	33335853	2020
26	Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands. ⁶²	Winter G...Kletting P	31260881	2019
27	Radiopotentiation of enzalutamide over human prostate cancer cells as assessed by real-time cell monitoring. ⁶²	Barrado M...Arias F	30858765	2019
28	Raman spectroscopy discriminates malignant follicular lymphoma from benign follicular hyperplasia and from tumour metastasis. ⁶²	Rau JV...Di Napoli A	30609603	2019
29	A Case of Mediastinal Lymph Node Carcinoma of Unknown Primary Site. ⁶²	Nakano T...Iwazaki M	30488402	2018
30	Development of pipette tip gap closure migration assay (s-ARU method) for studying semi-adherent cell lines. ⁶²	Sanmukh SG...Felisbino SL	30069611	2018
31	Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma. ⁶²	Luo H...Ge H	29143229	2018
32	Cervical lymph node carcinoma metastasis from unknown primary site: a retrospective analysis of 154 patients. ⁶²	Wang Y...Chen Y	29608251	2018
33	Lymph node cancer of the mediastinum with a putative necrotic primary lesion in the lung: a case report. ⁶²	Shikata D...Goto T	29606126	2018
34	Genome-Wide Methylation Patterns in Androgen-Independent Prostate Cancer Cells: A Comprehensive Analysis Combining MeDIP-Bisulfite, RNA, and microRNA Sequencing Data. ⁶²	Wang Y...Xu G	29324665	2018
35	[Long-Term Survival of a Patient with Metastatic Liver and Para-Aortic Lymph Node Cancer from Colon Cancer Treated with Regorafenib]. ⁶²	Watanabe N...Otsuji E	29394758	2017
36	Anticancer effect of Saussurea lappa extract via dual control of apoptosis and autophagy in prostate cancer cells. ⁶²	Tian X...Kang SC	28746210	2017
37	[The Diagnostic Value of Endobronchial Ultrasound-guided Needle Aspiration Biopsy for Lung or Mediastinal Lymph Node Cancer and Tuberculosis]. ⁶²	Wang Y...Li WM	28616904	2017
38	Preclinical Evaluation of 18F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer Imaging. ⁶²	Cardinale J...Kopka K	27789722	2017
39	Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity. ⁶²	Bedussi F...Berruti A	28797006	2017
40	Superporous Poly(ethylene glycol) Diacrylate Cryogel with a Defined Elastic Modulus for Prostate Cancer Cell Research. ⁶²	Goppert B...Cato AC	27240250	2016
41	Predictable Heating and Positive MRI Contrast from a Mesoporous Silica-Coated Iron Oxide Nanoparticle. ⁶²	Hurley KR...Haynes CL	26991550	2016
42	A comparison of novel organoiridium(III) complexes and their ligands as a potential treatment for prostate cancer. ⁶²	Hockey SC...Henderson LC	26802546	2016
43	Formation of Tethers from Spreading Cellular Aggregates. ⁶²	Beaune G...Brochard-Wyart F	26509898	2015
44	Is Stereotactic Body Radiotherapy (SBRT) in lymph node oligometastatic patients feasible and effective? ⁶²	Jereczek-Fossa BA...Orecchia R	26696788	2015
45	Physical diseases as predictors of suicide in older adults: a nationwide, register-based cohort study. ⁶²	Erlangsen A...Conwell Y	25835959	2015
46	The overview of cancer patients attending in a specialized hospital: A cross sectional study. ⁶²	Paul TK...Monower MM	29624288	2015
47	Hibiscus sabdariffa Leaf Extract Inhibits Human Prostate Cancer Cell Invasion via Down-Regulation of Akt/NF-kB/MMP-9 Pathway. ⁶²	Chiu CT...Lin HH	26115086	2015
48	Voltage-Gated Potassium Channels Kv1.3--Potentially New Molecular Target in Cancer Diagnostics and Therapy. ⁶²	Teisseyre A...Michalak K	26467143	2015
49	Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells. ⁶²	Weaver EM...Martin-Caraballo M	25557765	2015
50	ZnFe2O4 nanoparticles as radiosensitizers in radiotherapy of human prostate cancer cells. ⁶²	Meidanchi A...Khansari N	25492003	2015

Sources

Genes for Lymph Node Carcinoma

Genes related to Lymph Node Carcinoma (0 elite genes):

(show all 21)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	H2AC18	H2A Clustered Histone 18	Protein Coding	13.45	DISEASES inferred ¹⁴ ¹⁴ ¹⁴ ¹⁴
2	AR	Androgen Receptor	Protein Coding	12.05	DISEASES inferred ¹⁴ ¹⁴
3	LRRC26	Leucine Rich Repeat Containing 26	Protein Coding	11.06	DISEASES inferred ¹⁴ ¹⁴
4	FOLH1	Folate Hydrolase 1	Protein Coding	10.88	DISEASES inferred ¹⁴ ¹⁴
5	LRRC52	Leucine Rich Repeat Containing 52	Protein Coding	10.51	DISEASES inferred ¹⁴ ¹⁴
6	LRRC38	Leucine Rich Repeat Containing 38	Protein Coding	10.5	DISEASES inferred ¹⁴ ¹⁴
7	LRRC55	Leucine Rich Repeat Containing 55	Protein Coding	10.29	DISEASES inferred ¹⁴ ¹⁴
8	REV3L	REV3 Like, DNA Directed Polymerase Zeta Catalytic Subunit	Protein Coding	10.1	DISEASES inferred ¹⁴ ¹⁴
9	KLK3	Kallikrein Related Peptidase 3	Protein Coding	10.01	DISEASES inferred ¹⁴ ¹⁴
10	H2AZ2	H2A.Z Variant Histone 2	Protein Coding	9.88	DISEASES inferred ¹⁴ ¹⁴
11	DNTTIP1	Deoxynucleotidyltransferase Terminal Interacting Protein 1	Protein Coding	9.58	DISEASES inferred ¹⁴ ¹⁴
12	LINC01496	Long Intergenic Non-Protein Coding RNA 1496	RNA Gene	9.57	DISEASES inferred ¹⁴ ¹⁴
13	TCAF1	TRPM8 Channel Associated Factor 1	Protein Coding	9.52	DISEASES inferred ¹⁴ ¹⁴
14	TRPM8	Transient Receptor Potential Cation Channel Subfamily M Member 8	Protein Coding	9.5	DISEASES inferred ¹⁴ ¹⁴
15	TRPM4	Transient Receptor Potential Cation Channel Subfamily M Member 4	Protein Coding	9.41	DISEASES inferred ¹⁴ ¹⁴
16	FER1L6-AS1	FER1L6 Antisense RNA 1	RNA Gene	9.39	DISEASES inferred ¹⁴ ¹⁴
17	TRPC1	Transient Receptor Potential Cation Channel Subfamily C Member 1	Protein Coding	9.29	DISEASES inferred ¹⁴ ¹⁴
18	NME6	NME/NM23 Nucleoside Diphosphate Kinase 6	Protein Coding	9.28	DISEASES inferred ¹⁴ ¹⁴
19	OR2AT4	Olfactory Receptor Family 2 Subfamily AT Member 4	Protein Coding	9.25	DISEASES inferred ¹⁴ ¹⁴
20	H2AZ1	H2A.Z Variant Histone 1	Protein Coding	9.22	DISEASES inferred ¹⁴ ¹⁴
21	KCNMA1	Potassium Calcium-Activated Channel Subfamily M Alpha 1	Protein Coding	9.2	DISEASES inferred ¹⁴ ¹⁴

Sources

Variations for Lymph Node Carcinoma

Sources

Expression for Lymph Node Carcinoma

Search GEO for disease gene expression data for Lymph Node Carcinoma.

Sources

Pathways for Lymph Node Carcinoma

Pathways related to Lymph Node Carcinoma according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	TRP channels ⁶⁶	10.25	TRPM8 TRPM4 TRPC1

Sources

GO Terms for Lymph Node Carcinoma

Cellular components related to Lymph Node Carcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	plasma membrane	GO:0005886	9.7	TRPM8 TRPM4 TRPC1 LRRC55 LRRC52 LRRC38
2	plasma membrane	GO:0005887	9.7	TRPM8 TRPM4 TRPC1 LRRC55 LRRC52 LRRC38
3	voltage-gated potassium channel complex	GO:0008076	9.56	LRRC55 LRRC52 LRRC38 LRRC26

Biological processes related to Lymph Node Carcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	potassium ion transmembrane transport	GO:0071805	9.76	LRRC55 LRRC52 LRRC38 LRRC26
2	regulation of systemic arterial blood pressure	GO:0003073	9.56	KLK3 AR
3	monoatomic ion transport	GO:0006811	9.5	TRPM8 TRPM4 TRPC1 LRRC55 LRRC52 LRRC38
4	positive regulation of voltage-gated potassium channel activity	GO:1903818	9.23	LRRC55 LRRC52 LRRC38 LRRC26

Molecular functions related to Lymph Node Carcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	calcium channel activity	GO:0005262	9.77	TRPM8 TRPM4 TRPC1
2	voltage-gated potassium channel activity	GO:0005249	9.76	LRRC26 LRRC38 LRRC52 LRRC55
3	monoatomic cation channel activity	GO:0005261	9.73	TRPM8 TRPM4 TRPC1
4	transmembrane transporter binding	GO:0044325	9.65	TCAF1 LRRC55 LRRC52 LRRC38 LRRC26
5	ligand-gated calcium channel activity	GO:0099604	9.62	TRPM8 TRPM4
6	potassium channel activator activity	GO:0099104	9.23	LRRC55 LRRC52 LRRC38 LRRC26

Sources

Sources for Lymph Node Carcinoma

¹ BitterDB

² CDC

³ Cell Signaling Technology

⁴ ClinicalTrials

⁵ ClinVar

⁶ CNVD

⁷ Cochrane Library

⁸ Cosmic

⁹ dbSNP

¹⁰ DGIdb

¹¹ Disease Ontology

¹² diseasecard

¹³ DiseaseEnhancer

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ EFO

¹⁷ ExPASy

¹⁸ FMA

¹⁹ GARD

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HMDB

³⁰ HPO

³¹ ICD10

³² ICD10 via Orphanet

³³ ICD11

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ LifeMap

³⁷ LncRNADisease

³⁸ LOVD

³⁹ MalaCards

⁴⁰ MedGen

⁴¹ MedlinePlus

⁴² MedlinePlus Genetics

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NINDS

⁵³ Novoseek

⁵⁴ Novus Biologicals

⁵⁵ ODiseA

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 08-Dec-2022)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubChem

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ WikiPathways

⁷⁵ Wikipedia

MCID: LYM157 MIFTS: 34	Lymph Node Carcinoma Categories: Cancer diseases, Immune diseases, Rare diseases	Data Licensing For inquiries, contact: [email protected]
Genes Tissues Related diseases Publications Drugs Expand all tables